S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Halper Sadeh Launches Investigations into BCO, SEM, and NATL Mergers

Investors are scrutinizing the fairness of recent corporate acquisitions as New York law firm Halper Sadeh LLC opens investigations into The Brink's Company, Select Medical Holdings, and NCR Atleos. Attorneys are evaluating whether these deals improperly favor insiders or suppress competitive offers, potentially compromising the value held by ordinary shareholders.

Halper Sadeh Launches Investigations into BCO, SEM, and NATL Mergers
Photo: Bio & News

The firm is currently reviewing The Brink's Company (NYSE: BCO) regarding its merger with NCR Atleos Corporation, a deal structured to leave Brink’s shareholders with approximately 78% of the combined entity. Simultaneously, the investigation targets the sale of Select Medical Holdings Corporation (NYSE: SEM) to an executive-led consortium for $16.50 per share, alongside the acquisition of NCR Atleos Corporation (NYSE: NATL) for a mix of $30.00 in cash and 0.1574 Brink’s shares per unit.

Legal representatives suggest these transactions may contain restrictive terms that hinder superior bids or fail to provide adequate consideration for public investors. Halper Sadeh LLC, based at One World Trade Center, intends to seek increased compensation or enhanced disclosures to address potential breaches of fiduciary duty. Shareholders affected by these developments are encouraged to examine their legal options, as the firm operates on a contingent fee basis for these inquiries.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!